27.01.2010 • NewsJohnson Matthey

Johnson Matthey Sees Recovery in Key Markets

Johnson Matthey has reported that it had seen the beginnings of recovery in many of its key markets in the last three months of 2009. Sales for the fiscal third quarter excluding precious metals were 9% ahead of a year earlier and underlying pretax profit was up 20% as the company said it continued to benefit from reduced interest costs due to low borrowings and lower interest rates. The company said adjusted pretax profit for the full year is now expected to be slightly ahead of the current market consensus of $391 million.

Company

Johnson Matthey

Orchard Road
SG8 5HE Royston, Herts
UK

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.